Cite

HARVARD Citation

    Battat, R. et al. (2019). Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflammatory bowel diseases. 25 (2), p. . [Online]. 
  
Back to record